Search

Search Constraints

You searched for: Author/Creator Federico, Alessandro

Search Results

31. Symbiotic formulation in experimentally induced liver fibrosis in rats: intestinal microbiota as a key point to treat liver damage?. (1st March 2013)

32. Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy. Issue 1 (31st December 2023)

33. The management of pseudomyogenic hemangioendothelioma of the foot: A case report and review of the literature. Issue 6 (21st September 2018)

34. Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19. Issue 10 (October 2022)

35. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments. Issue 2 (February 2015)

36. Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments. Issue 2 (February 2015)

37. Urotensin‐II receptor is over‐expressed in colon cancer cell lines and in colon carcinoma in humans. (22nd January 2014)

38. Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets. (12th April 2018)